Press Tag: Milo Biotechnology

Categories
Becker Muscular Dystrophy Drug Market 2022 Future Developments – Italfarmaco SpA, Milo Biotechnology LLC, PTC Therapeutics Inc, ReveraGen BioPharma Inc
Becker Muscular Dystrophy Drug Market 2022 Future Developments – Italfarmaco SpA, Milo Biotechnology LLC, PTC Therapeutics Inc, ReveraGen BioPharma Inc
Nationwide Children’s spinoff raises funds for muscular dystrophy gene therapy trials from Rev1, JumpStart
Columbus Business First
Company News
Nationwide Children’s spinoff raises funds for muscular dystrophy gene therapy trials from Rev1, JumpStart
Milo Biotechnology Announces FDA Orphan Drug Designation for Treatment of Inclusion Body Myositis
Company News
Milo Biotechnology Announces FDA Orphan Drug Designation for Treatment of Inclusion Body Myositis
Milo Biotechnology Raises Funding from JumpStart and Rev1 Ventures
Company News
Milo Biotechnology Raises Funding from JumpStart and Rev1 Ventures
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
Rev1 News
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
Rev1 News
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
Rev1 Ventures and Nationwide Children’s Hospital Launch New Fund to Support Healthcare Innovators
Rev1 News
Rev1 Ventures and Nationwide Children’s Hospital Launch New Fund to Support Healthcare Innovators
Little Milo Wrestles For Gene Therapy Spotlight
Company News
Little Milo Wrestles For Gene Therapy Spotlight
Nationwide Children’s gene therapy lands TechColumbus investment (Milo Biotechnology)
Columbus Business First
Company News
Nationwide Children’s gene therapy lands TechColumbus investment (Milo Biotechnology)